לפתיחת המצגות יש ללחוץ על שם ההרצאה מעל לכל סרטון.

Opening Remarks - Dr. Noa Efrat Ben-Baruch

What is HER2 positive breast cancer in 2018? Updated ASCO-CAP guidelines - Prof. Giuseppe Viale

Navigating HER2-positive eBC treatment: How to fully optimize treatment? - Prof. Sibylle Loibl

Panel: HER2-positive Early BC treatment – Dilemmas and Practical Considerations 

Best of ASCO in Breast Cancer - Dr. Einav Gal-Yam

Translational Research in Breast Cancer - Biologics and Immunotherapy - Prof. Sibylle Loibl

Case Studies - Tumor Board Discussion - Illustrative Cases Incorporating Current and New Data

Case 1 - Pregnancy in HER2 Positive Early Breast

Case 2 - Management of Oligometastatic Breast Cancer

Case 3 - Optimizing Treatments in Triple Negative

Case 4 - Beyond CDK Treatment in mBC HR+ Patients

נושאים קשורים:  כנסים